Anthony R. Mato, MD, MSCE, examines real-world data on testing and treatment in patients with chronic lymphocytic leukemia (CLL), commenting on pro......READ MORE
Reviewing data from the 63rd ASH Annual Meeting and Exposition, Anthony R. Mato, MD, MSCE, comments on novel-novel combinations, such as ibrutinib ......READ MORE
Comprehensive care in chronic lymphocytic leukemia (CLL) ranges from understanding the patient’s treatment preferences to counseling them on recomm......READ MORE
Long-term data reported at the 63rd ASH Annual Meeting and Exposition reflected advancements in chronic lymphocytic leukemia (CLL), such as improve......READ MORE
First-line treatment for chronic lymphocytic leukemia (CLL) was the focus of several presentations at the 63rd ASH Annual Meeting and Exposition. O......READ MORE
At the 63rd ASH Annual Meeting and Exposition, updated long-term data were reported from several trials of preferred frontline therapies for chroni......READ MORE